Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial (Q39537308)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 July 2016
edit
Language Label Description Also known as
English
Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
scientific article published on 29 July 2016

    Statements

    Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial (English)
    Victoria Atkinson
    Gabrielle Liszkay
    Anna Maria Di Giacomo
    Luis de la Cruz-Merino
    Caroline Dutriaux
    Daniel O Koralek
    Isabelle Rooney

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit